MedPath

MCCE in Assessing Efficacy of Gastro-oesophageal Varices

Not Applicable
Conditions
Gastroesophageal Varices
Interventions
Device: Magnetically controlled capsule endoscopy
Registration Number
NCT04984863
Lead Sponsor
Ruijin Hospital
Brief Summary

This study proposed for the first time the use of MCE to evaluate the efficacy of the treatment of gastroesophageal varices, and compared the examination results with the gold standard to explore whether MCE could replace the electronic gastroscopy as the preferred non-invasive evaluation method for the treatment of gastroesophageal varices.

Detailed Description

Gastro-esophageal varices is one of the complications of portal hypertension in cirrhosis. For patients with moderate to severe varicose veins, international guidelines recommend active treatment, including endoscopic therapy such as endoscopic band ligation (EBL) and interventional radiotherapy such as balloon-occluded retrograde transvenous obliteration (B-RTO)Electronic gastroscopy is the gold standard for the diagnosis of varicose veins at higher blood risk (varicose veins requiring retreatment). However, it is relatively invasive and uncomfortable in the examination process, so that patients with gain-and-compensation cirrhosis are often unwilling to accept it, which is not conducive to the standardized follow-up after the treatment of gastro-esophageal varices.Magnetically controlled capsule endoscopy (MCE) is a non-invasive detection method independently developed in China that covers the whole digestive tract (except colon) mucosa. Patients only need to swallow a capsule endoscope to make repeated observation for many times, and the examination process is painless. It is an ideal method for diagnosing varicose veins with high blood risk (varicose veins that need treatment). Therefore, this study proposed for the first time the use of MCE to evaluate the efficacy of the treatment of gastroesophageal varices, and compared the examination results with the gold standard to explore whether MCE could replace the electronic gastroscopy as the preferred non-invasive evaluation method for the treatment of gastroesophageal varices.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
96
Inclusion Criteria
  • 18-75 years old
  • Confirmed cirrhosis by clinical or pathological biopsy
  • Previous endoscopic treatment of esophageal and gastric varices, including but not limited to sclerotherapy, injection of tissue adhesives, skin entrapment, etc
  • Electronic gastroscopy is to be performed
  • Voluntary informed consent
Exclusion Criteria

Absolute contraindications:

  • Patients without surgical conditions or refusing any abdominal surgery (once the capsule is stranded, it cannot be removed by surgery)
  • There is a pacemaker in the body, except that the pacemaker is a new MRI compatible product
  • Electronic devices such as cochlear implants, magnetic metal drug infusion pumps, nerve stimulators and magnetic metal foreign bodies are implanted in the body;
  • .Women during pregnancy

Relative contraindication:

  • Gastrointestinal obstruction, stenosis, and fistula are known or suspected
  • Dysphagia

Study & Design

Study Type
INTERVENTIONAL
Study Design
SINGLE_GROUP
Arm && Interventions
GroupInterventionDescription
magnetically controlled capsule endoscopyMagnetically controlled capsule endoscopymagnetically controlled capsule endoscopy to evaluate the efficacy of the treatment of gastroesophageal varices
Primary Outcome Measures
NameTimeMethod
Evaluating the clinical usefulness of MCE in assessing the efficacy of gastro-oesophageal varices treated under gastroscopy.15-30 minutes

Comparing the value of MCE and gastroscopy in the grading of esophagogastric varices

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Ruijin Hospital

🇨🇳

Shanghai, Shanghai, China

© Copyright 2025. All Rights Reserved by MedPath